William Andrew Yeudall

8PUBLICATIONS
7CO-AUTHORS
Tumour immunologyPredictive and prognostic markersHaematological tumoursMolecular targetsSynchrotrons and accelerators not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 21, 2025
A single cysteine residue in vimentin regulates long non-coding RNA XIST to suppress epithelial-mesenchymal transition and stemness in breast cancer.

Saima Usman, William Andrew Yeudall, Muy-Teck Teh

|Dec 23, 2022
Transcriptome Analysis Reveals Vimentin-Induced Disruption of Cell-Cell Associations Augments Breast Cancer Cell Migration.

Saima Usman, Ahmad Jamal, Antesar Bushaala

|Jan 30, 2021
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3.

Catherine A Vaughan, Shilpa Singh, Mark A Subler

|Jul 10, 2020
EPS8 phosphorylation by Src modulates its oncogenic functions.

Linah A Shahoumi, Hesam Khodadadi, Husam Bensreti

|May 28, 2020
New tools to dissect the cancer genome.

Linah Shahoumi, Andrew Yeudall

|Aug 30, 2019
Targeted therapies for non-HPV-related head and neck cancer: challenges and opportunities in the context of predictive, preventive, and personalized medicine.

Linah A Shahoumi, W Andrew Yeudall

Pageof 2

Frequent Collaborators

2 joint publications

Muy-Teck Teh

2 joint publications

Ahmad Waseem

1 joint publications

Raghavendra Pillappa

1 joint publications

Sumitra Deb